KLAS Contact
Contact KLAS
Contact KLAS
2025 BEST IN KLAS
Preferences
Related Series
Related Segments
Data Analytics Platforms for Payers 2025
An Initial Look at Validated Capabilities & Customer Experience
Author
Bradley Hunter
Author
Jennifer Hickenlooper
Author
Tyson Blauer
Faced with the financial and staffing constraints currently pervasive in healthcare, payer organizations are continually looking to reduce costs and improve outcomes for their members. To do so, many payer organizations are relying on data analytics solutions to provide strong data visibility, which helps them create efficiencies and make more informed decisions. This report is KLAS’ initial look at payer customer experiences with data analytics vendors, including the breadth of adopted capabilities and the key factors impacting satisfaction. The report shares performance data for three of the vendors included in KLAS’ 2024 vendor guide, in which data analytics vendors were asked to self-report their areas of focus. KLAS intends to collect data on additional vendors and include them in future reports (see section on additional vendors at the end of the report).
If you don't have a login, getting started is easy.
Key Findings:
- MedInsight Customers Report Broadest Adoption of Capabilities; Slow Transition to Cloud-Based Platform Driving Some Dissatisfaction
- MedeAnalytics Customers Appreciate Responsive Support; Some Want a More Proactive Partnership to Further Drive Outcomes
- Strong Service Drives Satisfaction for Clarify Health Solutions* Customers
*Limited data
Writer
Carlisa Cramer
Designer
Kath Spencer
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2025 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.